Under construction – not a live service
Sign in
Not yet taking people in TaiwanNo phase

Home Blood Pressure Self-Management With AI Chatbot Support for Resistant Hypertension

Tests home blood pressure self-management with AI chatbot support in adults with resistant hypertension.

Plain-language title generated from the registry record
Registry title: Self-Management of Blood Pressure in Resistant Hypertension

Key facts

Where
Kaohsiung City, Taichung, and Taipei, TaiwanSee the 5 sites

Where in Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial HospitalKaohsiung City, TaiwanNo longer taking part
  • Kaohsiung Veterans General HospitalKaohsiung City, TaiwanNo longer taking part
  • Taichung Veterans General HospitalTaichung, TaiwanNo longer taking part
  • National Taiwan University HospitalTaipei, TaiwanNo longer taking part
  • Taipei Veterans General HospitalTaipei, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Taichung Veterans General Hospital
Trial code
NCT06819241
Record updated
11 February 2025
Original description
The trial is a 12-month randomized, parallel-group study comparing three arms: (1) HBP self-management with AI chatbot support, (2) HBP self-management without AI chatbot support, and (3) usual care. The primary objective is to evaluate differences in blood pressure changes and medication compliance between groups at 6 and 12 months.Read full original descriptionShow less

Effectiveness of Self-Management of Blood Pressure on the Management of Resistant Hypertension

The trial is a 12-month randomized, parallel-group study comparing three arms: (1) HBP self-management with AI chatbot support, (2) HBP self-management without AI chatbot support, and (3) usual care. The primary objective is to evaluate differences in blood pressure changes and medication compliance between groups at 6 and 12 months.

Inclusion: ≥18 years of age; receiving ≥3 antihypertensive medications of different classes, including a diuretic, and baseline BP >130/80 mmHg; or receiving ≥ 4 medications regardless of BP.

Exclusion: poor adherence to medication; an acute cardiovascular event in the previous 3 months; terminal disease; unable to conduct self-monitor BP because of cognitive dysfunction; poor digital capabilities; pregnant.

ClinicalTrials.gov NCT06819241